Jain Global’s Dyne Therapeutics DYN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-162,047
Closed -$3.17M 1318
2025
Q4
$3.17M Sell
162,047
-482,035
-75% -$9.13M 0.02% 505
2025
Q3
$8.15M Buy
644,082
+47,915
+8% +$546K 0.04% 270
2025
Q2
$5.68M Buy
+596,167
New +$6.56M 0.04% 312

Other funds holding DYN

Jain Global's DYN Position: Q1 2026 in Review

Jain Global sold out of Dyne Therapeutics (DYN) in Q1 2026, closing a stake of 162,047 shares — an estimated $3.17M sold.

Jain Global first reported a position in DYN in Q2 2025 and held it in 3 quarters. The position peaked at $8.15M in Q3 2025. 227 funds tracked by Wall St. Rank hold DYN as of Q1 2026.

  • Jain Global reported no remaining Dyne Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Jain Global sold 162,047 Dyne Therapeutics shares in Q1 2026, an estimated $3.17M.
  • Jain Global first reported a position in Dyne Therapeutics in Q2 2025 and held it in 3 quarters.
  • Jain Global's Dyne Therapeutics position peaked at $8.15M in Q3 2025.
  • 227 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q1 2026.

Based on Jain Global's 13F filing for Q1 2026, filed 15 May 2026.